When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APLS - Apellis on go file U.S. application for pegcetacoplan for rare blood disorder
Apellis Pharmaceuticals Inc.
On the heels of its meeting with the FDA, Apellis Pharmaceuticals (NASDAQ:APLS) announces that it expects to file a marketing application in H2 seeking approval of pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease in which the immune system destroys red blood cells.
More news on: Apellis Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., Healthcare stocks news,